Metraipolis › archive › dc_64afdb53dd9a

Vitiligo: Ruxolitinib and Other Oral Treatment Options Beyond Ruxolitinib — Europe PMC PMID:41117150

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41117150
DOI
10.1111/srt.70276
License (as archived)
solo-consultazione
Archived
2026-11-09T15:52:27.072Z
SHA-256 of the archived text
19ce635e5a6292c19c25229ca0b7d7d10e862df534ae12fb687dc15e3f6abe6d
Stable URL of this page
https://metraipolis.com/documento/dc_64afdb53dd9a

How to cite

Vitiligo: Ruxolitinib and Other Oral Treatment Options Beyond Ruxolitinib — Europe PMC PMID:41117150 — Europe PMC (en), https://europepmc.org/article/MED/41117150 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_64afdb53dd9a (Metraipolis archive dc_64afdb53dd9a, sha256 19ce635e5a6292c19c25229ca0b7d7d10e862df534ae12fb687dc15e3f6abe6d)
BibTeX
@misc{dc64afdb53dd9a,
  title = {Vitiligo: Ruxolitinib and Other Oral Treatment Options Beyond Ruxolitinib — Europe PMC PMID:41117150},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41117150},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_64afdb53dd9a; sha256 19ce635e5a6292c19c25229ca0b7d7d10e862df534ae12fb687dc15e3f6abe6d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41117150. Agents can read the archived copy with the MCP tool read_document.